Overall survival and long-term safety of olaparib maintenance in patients with platinum-sensitive relapsed ovarian cancer: final analyses of phase III L-MOCA trial
Abstract Background The indications for Poly(ADP-ribose) polymerase (PARP) inhibitor maintenance therapy in platinum-sensitive recurrent ovarian cancer (PSROC) patients varies across nations. The lack of clinical trial evidence and detailed biomarker analysis in the Asian population results in uncer...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMC
2026-05-01
|
| Serier: | Journal of Ovarian Research |
| Fag: | |
| Online adgang: | https://doi.org/10.1186/s13048-026-02144-4 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
